Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Aotsuka

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Biological & Pharmaceutical Bulletin|February 1, 1994
Inhibitory activities of metal chelators on endothelin-converting enzyme. I. In vitro studiesN Ashizawa, H Okumura, F Kobayashi, et al.
Biological & Pharmaceutical Bulletin|February 1, 1994
Inhibitory activities of metal chelators on endothelin-converting enzyme. II. In vivo studiesN Ashizawa, H Okumura, F Kobayashi, et al.
Biological & Pharmaceutical Bulletin|April 1, 1994
Substituted 1,8-naphthyridin-2(1H)-ones as selective phosphodiesterase IV inhibitorsA Matsuura, N Ashizawa, R Asakura, et al.
Japanese Journal of Pharmacology|February 1, 1997
Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in ratsN Ashizawa, M Yoshida, Y Sugiyama, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Biological & Pharmaceutical Bulletin|February 1, 1994
Inhibitory activities of metal chelators on endothelin-converting enzyme. I. In vitro studiesN Ashizawa, H Okumura, F Kobayashi, et al.
Biological & Pharmaceutical Bulletin|February 1, 1994
Inhibitory activities of metal chelators on endothelin-converting enzyme. II. In vivo studiesN Ashizawa, H Okumura, F Kobayashi, et al.
Biological & Pharmaceutical Bulletin|April 1, 1994
Substituted 1,8-naphthyridin-2(1H)-ones as selective phosphodiesterase IV inhibitorsA Matsuura, N Ashizawa, R Asakura, et al.
Japanese Journal of Pharmacology|February 1, 1997
Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in ratsN Ashizawa, M Yoshida, Y Sugiyama, et al.
Pageof 3